Basel Medical Group Receives Nasdaq Delinquency Notification for Incomplete Annual Report
ByAinvest
Monday, Dec 1, 2025 4:31 pm ET1min read
BMGL--
Basel Medical Group Ltd (BMGL) has received a delinquency notification from Nasdaq due to an incomplete annual report for FY2025. The report lacked an auditor's opinion on the company's financial statements. BMGL has 60 days to submit a plan to regain compliance, with a possible extension to May 18, 2026. Trading on Nasdaq is not affected. The company is working with professionals to prepare a rectification plan.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet